Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Naples › NPI 1992968150
Hospital

Naples Community Hospital INC

Naples Community Hospital INC was paid $26.70M by Medicaid between Jan 2018 and Dec 2024, across 279 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.

33Billing provider infoNAPLES COMMUNITY HOSPITAL INC
NAPLES, FL 34102
33aNPI1992968150assigned 07/08/2008
33bProvider typePsychiatric Hospital
28Total paid$26.70M
24GClaims923,318
24DCodes billed279
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital providers in Florida

Rank by total paid#1 of 16
Median peer was paid$84K
This provider vs. median317×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201850,764$1.38M
2019176,122$4.60M
2020140,164$2.82M
2021209,197$5.16M
2022225,573$6.85M
202391,971$4.19M
2024incomplete29,527$1.70M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 64,832 59,764 $4.33M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 43,614 36,043 $4.08M
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility 9.6% 7,657 1,103 $2.55M
0202U Oncology (prostate), multianalyte, gene expression profiling 9.3% 19,735 18,477 $2.49M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6.0% 17,812 3,442 $1.61M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.1% 17,189 13,419 $1.37M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.2% 12,118 2,498 $866K
36415 Collection of venous blood by venipuncture 3.2% 43,841 27,972 $857K
G0378 Hospital observation service, per hour 2.6% 21,761 6,666 $693K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.6% 9,528 9,036 $688K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.5% 3,566 3,213 $676K
70450 Computed tomography, head or brain; without contrast material 2.2% 5,607 4,800 $593K
267 more codes
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.7% 6,153 $459K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.6% 3,312 $417K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.0% 4,717 $278K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.0% 5,062 $271K
80048 Basic metabolic panel (calcium, ionized) <1% 31,772 $208K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,056 $206K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 1,146 $198K
81003 <1% 16,944 $197K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 4,785 $183K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,196 $168K
87081 <1% 10,790 $150K
96361 Intravenous infusion, hydration; each additional hour <1% 4,520 $143K
80053 Comprehensive metabolic panel <1% 19,558 $141K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,578 $112K
76819 Fetal biophysical profile; without non-stress testing <1% 5,317 $105K
72125 Computed tomography, cervical spine; without contrast material <1% 1,506 $104K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,015 $104K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,526 $103K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,755 $81K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,445 $77K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,822 $76K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,351 $75K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,722 $74K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 6,521 $71K
59025 Fetal non-stress test <1% 778 $66K
71046 Radiologic examination, chest; 2 views <1% 11,061 $66K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 3,892 $62K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 569 $60K
81025 <1% 9,237 $57K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 4,663 $52K
76801 <1% 3,200 $52K
97162 <1% 801 $50K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,369 $50K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,802 $44K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,278 $43K
87086 Culture, bacterial; quantitative colony count, urine <1% 14,091 $43K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 567 $43K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,313 $43K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,829 $43K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 407 $40K
96375 Therapeutic injection; each additional sequential IV push <1% 9,229 $36K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,131 $35K
92650 <1% 806 $34K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 356 $33K
73610 <1% 994 $30K
71045 Radiologic examination, chest; single view <1% 9,907 $29K
85027 <1% 11,821 $29K
12011 <1% 592 $26K
74018 <1% 2,901 $26K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 44,260 $26K
73630 <1% 1,174 $26K
12001 <1% 473 $26K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,936 $24K
73130 <1% 957 $23K
87070 <1% 1,411 $23K
87486 <1% 1,130 $23K
87420 <1% 675 $22K
87077 <1% 5,259 $22K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 14,466 $20K
81001 <1% 16,941 $19K
87045 <1% 1,262 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,796 $17K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 224 $16K
85610 <1% 16,592 $15K
73110 <1% 582 $15K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,554 $14K
P9021 Red blood cells, each unit <1% 230 $14K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,664 $13K
J1644 Injection, heparin sodium, per 1000 units <1% 3,678 $13K
82270 <1% 454 $13K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,963 $12K
73030 <1% 747 $12K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 589 $11K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 50 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,676 $10K
72131 <1% 152 $10K
83735 <1% 13,059 $10K
84702 <1% 3,892 $10K
76821 <1% 1,906 $9K
83880 <1% 5,524 $9K
73090 <1% 452 $9K
84484 <1% 12,204 $9K
86900 <1% 4,949 $9K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 332 $9K
85730 <1% 14,494 $8K
36430 <1% 242 $8K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,209 $8K
93971 <1% 488 $8K
76825 <1% 130 $8K
80076 <1% 9,000 $8K
76820 <1% 1,329 $8K
73560 <1% 571 $8K
93017 <1% 354 $7K
96376 <1% 2,303 $7K
74019 <1% 1,549 $7K
76818 <1% 233 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,339 $7K
86850 <1% 3,458 $6K
70486 <1% 55 $6K
74022 <1% 1,291 $5K
87040 <1% 4,363 $4K
88304 <1% 462 $4K
82550 <1% 5,427 $4K
J1756 Injection, iron sucrose, 1 mg <1% 359 $4K
80061 Lipid panel <1% 2,634 $4K
82553 <1% 4,208 $4K
86901 <1% 4,579 $4K
83605 <1% 3,587 $3K
84443 Thyroid stimulating hormone (TSH) <1% 3,943 $3K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 155 $3K
83690 <1% 12,281 $3K
J1815 Injection, insulin, per 5 units <1% 1,945 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 208 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 13 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,218 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,971 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 3,012 $3K
85007 <1% 3,299 $3K
73590 <1% 192 $3K
76830 Ultrasound, transvaginal <1% 410 $3K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 208 $2K
29125 <1% 479 $2K
86140 <1% 5,958 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 120 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,152 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 765 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,429 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 2,652 $2K
73564 <1% 308 $2K
84100 <1% 3,131 $2K
96367 <1% 144 $2K
87186 <1% 3,574 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,710 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 26 $2K
87210 <1% 1,099 $2K
87205 <1% 1,589 $2K
73140 <1% 52 $2K
10060 <1% 96 $2K
82565 <1% 288 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,502 $1K
73620 <1% 58 $1K
84112 <1% 60 $1K
85379 <1% 2,539 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,299 $1K
97166 <1% 35 $1K
86920 <1% 298 $1K
82947 <1% 2,185 $1K
82330 <1% 426 $1K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 914 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 157 $1K
99213 Doctor's office visit, returning patient (routine) <1% 21 $1K
87581 <1% 1,098 $967.16
97161 <1% 14 $964.84
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 83 $839.36
76775 <1% 58 $816.42
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,413 $806.54
93325 <1% 68 $764.60
82150 <1% 3,925 $752.30
76770 <1% 29 $749.07
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,014 $706.45
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 302 $635.90
J2704 Injection, propofol, 10 mg <1% 592 $607.89
J7120 Ringers lactate infusion, up to 1000 cc <1% 810 $579.67
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 620 $576.42
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 14 $554.14
82962 <1% 83 $549.84
93970 <1% 72 $519.85
99203 Doctor's office visit, new patient (routine) <1% 26 $519.32
76827 <1% 131 $490.75
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 327 $490.39
73502 <1% 155 $486.85
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 851 $483.37
85652 <1% 2,957 $479.58
82248 <1% 2,373 $474.36
J2550 Injection, promethazine hcl, up to 50 mg <1% 786 $470.37
82728 <1% 1,146 $418.37
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 167 $415.62
84439 <1% 345 $349.08
83615 <1% 798 $303.75
85384 <1% 210 $293.29
86308 <1% 465 $263.61
84703 <1% 1,468 $261.11
J3370 Injection, vancomycin hcl, 500 mg <1% 302 $251.97
84145 <1% 476 $234.92
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 19 $221.05
C1769 Guide wire <1% 53 $221.05
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 867 $213.01
J2060 Injection, lorazepam, 2 mg <1% 1,149 $213.01
72100 <1% 62 $209.72
72110 <1% 12 $205.35
90715 <1% 367 $203.35
90714 <1% 125 $202.45
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,753 $199.88
83550 <1% 442 $192.46
87046 <1% 1,016 $183.33
J0561 Injection, penicillin g benzathine, 100,000 units <1% 61 $181.49
51701 <1% 1,085 $175.19
88342 <1% 162 $167.57
82607 <1% 247 $158.28
87340 <1% 611 $157.53
J3105 Injection, terbutaline sulfate, up to 1 mg <1% 164 $148.35
84436 <1% 326 $127.23
82805 <1% 229 $118.37
93975 <1% 19 $114.27
82375 <1% 301 $113.67
83540 <1% 676 $111.03
83050 <1% 215 $104.27
87015 <1% 29 $65.43
83970 <1% 130 $41.60
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,430 $37.95
73070 <1% 14 $35.85
87147 <1% 292 $32.10
84550 <1% 418 $27.62
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 895 $25.43
84466 <1% 127 $20.25
85014 <1% 641 $18.55
84479 <1% 229 $17.21
84520 <1% 92 $14.04
84460 <1% 122 $12.56
84450 <1% 122 $12.56
84132 <1% 1,117 $12.39
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 12 $11.95
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 343 $9.15
87427 <1% 1,270 $8.74
82570 <1% 29 $8.06
85018 <1% 1,017 $7.41
82803 <1% 111 $3.90
82746 <1% 64 $3.34
84295 <1% 209 $3.14
83930 <1% 29 $2.96
85045 <1% 93 $1.80
84156 <1% 31 $1.56
J7510 Prednisolone oral, per 5 mg 0% 85 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 975 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 16 $0.00
87899 0% 137 $0.00
88312 0% 12 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 69 $0.00
82140 0% 53 $0.00
99152 0% 13 $0.00
73080 0% 32 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 32 $0.00
29105 0% 39 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 15 $0.00
Q3014 Telehealth originating site facility fee 0% 1,803 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 514 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 220 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 166 $0.00
94760 0% 162 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 0% 31 $0.00
12002 0% 14 $0.00
P9612 Catheterization for collection of specimen, single patient, all places of service 0% 28 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 123 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 39 $0.00
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 0% 35 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 0% 50 $0.00
80329 0% 26 $0.00
82040 0% 45 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 23 $0.00
72170 0% 14 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 50 $0.00
80069 0% 124 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 58 $0.00
87449 0% 14 $0.00
76870 0% 15 $0.00
J2780 Injection, ranitidine hydrochloride, 25 mg 0% 36 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 24 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWOOD, SANDRA (OPERATIONS DIRECTOR OF REVENUE CYCL)
Parent organizationNAPLES COMMUNITY HOSPITAL INC